Niferidil
Trade name: Refralon
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 26, 2022 (NCT05445297)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06540352 | Phase 2 | Jun 3, 2024 | Government of Russia |
| NCT05456204 | N/A | Feb 15, 2022 | Government of Russia |
| NCT05445297 | N/A | Jan 26, 2022 | Government of Russia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1